Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 452

Results For "EU"

5718 News Found

Amyris commissions industry-leading fermentation plant
Biotech | April 11, 2022

Amyris commissions industry-leading fermentation plant

The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products


Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility
Clinical Trials | April 11, 2022

Venkaiah Naidu inaugurates India’s first ‘integrated diagnostics’ facility

Mahajan Imaging, which currently has 10 high-end medical diagnostic centres in Delhi-NCR and Jaipur, has ventured into a new field called Integrated Diagnostics


LivaNova initiates targeted commercial launch of Essenz patient monitor
Biotech | April 10, 2022

LivaNova initiates targeted commercial launch of Essenz patient monitor

An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe


New research on drug-induced gene signatures for colorectal cancer patients
Biotech | April 10, 2022

New research on drug-induced gene signatures for colorectal cancer patients

Data to be presented at the 2022 AACR annual meeting highlights the unique nature of post-chemotherapy derived gene expression signatures in stratifying patient outcomes


Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial
Biotech | April 10, 2022

Innovative therapy that ‘tricks’ and destroys cancer cells advance to clinical trial

Results from pre-clinical research show iron-like compound hold promise for treating patients with glioblastoma, an aggressive brain cancer


Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
Biotech | April 08, 2022

Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer

The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC


Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells
Biotech | April 08, 2022

Essent Biologics launches Wharton's jelly-derived human mesenchymal stromal cells

Essent continues to broaden its highly characterized, low passage primary cell catalog


IAVI and Moderna partner to tackle broad global health priorities
Biotech | April 08, 2022

IAVI and Moderna partner to tackle broad global health priorities

Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis


CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India
Biotech | April 08, 2022

CDSCO approves Phase II/III trial of Akston Bio’s Covid vaccine candidate in India

Veeda Clinical Research will submit data in an application for Emergency Use Authorisation


Ineos to build acetonitrile plant in Germany
News | April 08, 2022

Ineos to build acetonitrile plant in Germany

The new unit will be built with INEOS’ latest process technology and aims to substantially improve the sustainability of our supply to our customers and reduce our environmental impact